Table 6 Comparison of median percent fluid overload upon initiation of CRRT in all patients, survivors, and non-survivors between eras (median (inter-quartile range)), as well as over the 10-year study period
Principal Diagnosis | 2004–2008 | 2009–2013 | 2004–2013 | ||||||
|---|---|---|---|---|---|---|---|---|---|
All Patients | Survivors | Non-survivors | All Patients | Survivors | Non-survivors | All Patients | Survivors | Non-survivors | |
Cardiac | 19 (2, 26) | 5 (2, 22) | 20 (19, 33) | 4 (3, 11) | 12 (3,29) | 4 (0, 7) | 7 (2, 22) | 9 (3, 24) | 7 (0, 20) |
Renal | 10 (6, 30) | 10 (6, 30) | – | 23 (13, 30) | 17 (13, 30) | 28 (28,28) | 20 (12, 30) | 17 (11, 30) | 28 (28, 28) |
Liver | 20 (15, 31) | 37 (17, 42) | 18 (14, 24) | 20 (12, 30) | 19 (12, 30) | 20 (12, 30) | 20 (12, 30) | 20 (12, 35) | 19 (13, 27) |
Hematology/ Oncology | 15 (8, 22) | 20 (12, 22) | 12 (8, 15) | 17 (5, 29) | 14 (0, 29) | 21 (5, 29) | 17 (8, 28) | 17 (8, 22) | 16 (8, 29) |
Bone marrow transplant | 16 (10, 20) | 15 (9,20) | 16 (10, 20) | 10 a (7, 12) | 9 (7, 11) | 10 (7, 13) | 11 (9, 18) | 10 (8, 12) | 11 (10, 19) |
Pulmonary | 15 (9, 18) | 20 (5, 26) | 15 (11, 15) | 13 (4, 22) | 13 (8, 18) | 13 (0, 25) | 15 (7, 19) | 18 (8, 20) | 15 (7, 16) |
Inborn Error of Metabolism | 0 (0, 0) | 0 (0, 0) | – | 0 (0, 16) | 0 (0, 0) | 17 (0, 35) | 0 (0, 16) | 0 (0, 0) | 17 (0, 35) |
Sepsis | 20 (9, 28) | 8 (0, 21) | 25 (13, 30) | 22 (20, 38) | 17 (12, 22) | 38 (20, 46) | 21 (12, 30) | 12 (8, 21) | 27 b (19, 34) |
Neonates | 20 (9, 32) | 21 (8, 39) | 20 (20, 20) | 14 (0, 26) | 6 (0, 14) | 26 b (14, 37) | 14 (6, 29) | 10 (0, 15) | 23 (14, 37) |
Other c | 21 (13, 40) | 21 (13, 28) | 28 (12, 48) | 11 (4, 21) | 17 (5, 21) | 4 (0, 12) | 17 (8, 30) | 17 (10, 28) | 12 (4, 36) |